Skip to content
PubMed This is a summary of 19 peer-reviewed journal articles Updated
Neurology

Understanding Your Diagnosis: Familial Hemiplegic Migraine

At a Glance

Familial hemiplegic migraine is diagnosed when a person has at least two attacks with temporary one-sided weakness, other reversible symptoms such as visual changes or tingling, and a compatible family history. A negative genetic test does not rule it out.

Receiving a diagnosis of Familial Hemiplegic Migraine (FHM) can feel overwhelming, especially since the symptoms can look and feel so much like a stroke. However, FHM is a distinct, rare, and primarily genetic neurological condition. Unlike a typical migraine, which many people think of as “just a bad headache,” FHM is a complex event involving temporary changes in how your brain cells communicate [1][2].

What FHM Does and Does Not Mean

  • Migraine is not just a headache: It is a neurological event, and in FHM, the aura (weakness and sensory changes) is often the most prominent feature.
  • A negative genetic test does not invalidate a clinical diagnosis: Because we do not yet know all the genes involved, your clinical history is what matters most.

Understanding your diagnosis starts with two key factors: the specific nature of your symptoms and your family history.

What Makes a Migraine “Hemiplegic”?

In the medical world, hemiplegia refers to weakness on one side of the body. For a diagnosis of hemiplegic migraine, you must experience aura (reversible neurological symptoms) that includes physical weakness [1][3].

According to the International Classification of Headache Disorders (ICHD-3), a diagnosis of FHM requires:

  • At least two attacks that include fully reversible motor weakness [1].
  • Other aura symptoms, such as seeing flashing lights (visual aura), feeling “pins and needles” (sensory aura), or having trouble finding words (speech/language aura) [1][4].
  • At least one first-degree relative (parent, sibling, or child) or second-degree relative (grandparent, aunt, uncle, or grandchild) who has also had these specific types of attacks meeting compatible hemiplegic-migraine criteria [2][5].

Additionally, the ICHD-3 outlines specific aura characteristics for diagnosis, requiring at least three of the following [1][4]:

  • At least one aura symptom spreading gradually over 5 minutes or more.
  • Two or more aura symptoms occurring in succession.
  • Individual non-motor aura symptoms lasting 5–60 minutes.
  • Motor weakness usually lasting less than 72 hours (though rarely it can persist longer).
  • At least one aura symptom that is unilateral (on one side).
  • The aura is accompanied or followed by a headache within 60 minutes.

If you have these symptoms but no family history of them, the condition is called Sporadic Hemiplegic Migraine. FHM is essentially the same condition but with a clear genetic link through your family tree [6].

How Rare is This Condition?

FHM is exceptionally rare. While migraines affect about 12% of the general population, hemiplegic migraine is estimated to affect only about 0.01%—or roughly 1 in 10,000 people [2]. Because it is so uncommon, it is often misdiagnosed as epilepsy or a stroke, sometimes taking years for patients to receive the correct diagnosis [6][7].

The Biology: Why the Weakness Happens

To understand FHM, it helps to think of your brain as a highly tuned electrical grid. Your brain cells (neurons) send signals using “gates” called ion channels and ion-transport proteins. These channels control the flow of chemicals like calcium, sodium, and potassium.

In FHM, genetic mutations cause these gates to malfunction. This makes the brain “irritable” or hypersensitive [8][9]. When triggered, this sensitivity leads to a phenomenon called Cortical Spreading Depression (CSD) [10].

  1. The Wave: CSD is a slow-moving wave of intense electrical activity (depolarization) that sweeps across the surface of the brain, followed by a period of suppression [11].
  2. The Shutdown: As the wave passes, it leaves the neurons temporarily “exhausted” and unable to fire properly.
  3. The Symptoms: The area of the brain affected by this wave determines your symptoms. If the wave involves the part of the brain that controls movement, you experience the signature one-sided weakness [1][4].

The Role of Genetics

Many cases of FHM are caused by a mutation in one of three specific principal genes. These genes provide the instructions for building the ion channels and pumps mentioned above:

Gene Type Technical Name What it Does
FHM1 CACNA1A Controls calcium “gates.” Mutations here can sometimes be triggered by minor head trauma [8][12].
FHM2 ATP1A2 Helps “clean up” chemicals (like potassium and glutamate) between brain cells as a sodium-potassium pump. If this doesn’t work, the brain stays over-excited [13][14].
FHM3 SCN1A Controls sodium “gates” that help neurons fire. Mutations can make certain cells hyperactive, triggering the CSD wave [15][16].

It is important to note that known CACNA1A, ATP1A2, and SCN1A variants account for only a minority of clinically diagnosed cases. You can still have FHM even if your genetic tests are negative. Scientists believe there are other genes involved that have not yet been identified [6][17].

Beyond the Headache

FHM is not just a severe headache; it is a systemic neurological event. For some people in selected families, attacks can be accompanied by fever, confusion, or even seizures [12][5]. Some genetic forms (particularly FHM1) are also reported to associate with ataxia, an episodic, static, or permanent coordination or balance issue that may develop [18][19]. Understanding your specific genetic subtype can help your medical team monitor for these associated conditions and tailor your care appropriately.

Common questions in this guide

What is required for a diagnosis of familial hemiplegic migraine?
Clinicians look for at least two attacks with fully reversible weakness on one side and other reversible aura symptoms, such as visual, sensory, or speech changes. A parent, sibling, child, grandparent, aunt, uncle, or grandchild must also have had compatible attacks, and clinicians review the timing, duration, and progression of the symptoms.
Can familial hemiplegic migraine be diagnosed if genetic testing is negative?
Yes. Known changes in CACNA1A, ATP1A2, and SCN1A explain only a minority of clinically diagnosed cases, so doctors can rely on the attack pattern and family history when testing does not identify a cause.
How can I tell a hemiplegic migraine from a stroke?
Both can cause one-sided weakness and other neurological symptoms, so a new, severe, or unusual attack should be treated as a medical emergency until stroke is ruled out. Although migraine symptoms are reversible, only prompt medical evaluation can safely distinguish the causes.
Which genes are linked to familial hemiplegic migraine?
The three best-known genes are CACNA1A, ATP1A2, and SCN1A, sometimes called FHM1, FHM2, and FHM3. They help control electrical signaling and chemical balance between brain cells, and knowing the gene may help clinicians tailor monitoring.
What symptoms can happen during an FHM attack?
Temporary weakness on one side is the defining feature, and an attack may also cause flashing lights or other visual changes, tingling, trouble speaking, and headache. Some people in selected families also experience fever, confusion, seizures, or balance and coordination problems.
How long can weakness last in familial hemiplegic migraine?
Motor weakness usually lasts less than 72 hours, although it can rarely continue longer. Because the symptoms can resemble stroke, seek urgent medical evaluation for a new or unusually persistent episode instead of waiting for it to resolve.

Get notified when new evidence is published on Familial hemiplegic migraine.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (19)
  1. 1

    Diagnostic and therapeutic aspects of hemiplegic migraine.

    Di Stefano V, Rispoli MG, Pellegrino N, et al.

    Journal of neurology, neurosurgery, and psychiatry 2020; (91(7)):764-771 doi:10.1136/jnnp-2020-322850.

    PMID: 32430436
  2. 2

    [Familial hemiplegic migraine].

    Starikova NL, Kulesh AA

    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 2021; (121(7)):114-117 doi:10.17116/jnevro2021121071114.

    PMID: 34460166
  3. 3

    Hemiplegic Migraine.

    Nandyala A, Shah T, Ailani J

    Current neurology and neuroscience reports 2023; (23(7)):381-387 doi:10.1007/s11910-023-01277-z.

    PMID: 37247170
  4. 4

    Pathophysiology of migraine aura.

    Sanchez Del Rio M, Cutrer FM

    Handbook of clinical neurology 2023; (198()):71-83 doi:10.1016/B978-0-12-823356-6.00016-0.

    PMID: 38043972
  5. 5

    Familial hemiplegic migraine.

    Villar-Martinez MD, Moreno-Ajona D, Goadsby PJ

    Handbook of clinical neurology 2024; (203()):135-144 doi:10.1016/B978-0-323-90820-7.00007-0.

    PMID: 39174245
  6. 6

    Hemiplegic migraine.

    de Boer I, Hansen JM, Terwindt GM

    Handbook of clinical neurology 2024; (199()):353-365 doi:10.1016/B978-0-12-823357-3.00015-X.

    PMID: 38307656
  7. 7

    Familial hemiplegic migraine in Indian children-a tertiary center experience.

    Saini L, Gunasekaran PK, Tiwari S, et al.

    Journal of tropical pediatrics 2024; (70(3)) doi:10.1093/tropej/fmae008.

    PMID: 38580379
  8. 8

    Abnormal cortical synaptic transmission in CaV2.1 knockin mice with the S218L missense mutation which causes a severe familial hemiplegic migraine syndrome in humans.

    Vecchia D, Tottene A, van den Maagdenberg AM, Pietrobon D

    Frontiers in cellular neuroscience 2015; (9()):8 doi:10.3389/fncel.2015.00008.

    PMID: 25741235
  9. 9

    Mechanisms underlying the increased susceptibility to initiation of cortical spreading depression in a genetic mouse model of migraine.

    Vitale M, Tottene A, Zadeh MZ, Pietrobon D

    The journal of headache and pain 2025; (26(1)):256 doi:10.1186/s10194-025-02139-4.

    PMID: 41233736
  10. 10

    Dynamics of Ionic Shifts in Cortical Spreading Depression.

    Enger R, Tang W, Vindedal GF, et al.

    Cerebral cortex (New York, N.Y. : 1991) 2015; (25(11)):4469-76 doi:10.1093/cercor/bhv054.

    PMID: 25840424
  11. 11

    Stroke-prone salt-sensitive spontaneously hypertensive rats show higher susceptibility to spreading depolarization (SD) and altered hemodynamic responses to SD.

    Kang EJ, Prager O, Lublinsky S, et al.

    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2023; (43(2)):210-230 doi:10.1177/0271678X221135085.

    PMID: 36329390
  12. 12

    Clinical spectrum of hemiplegic migraine and chances of finding a pathogenic mutation.

    Pelzer N, Haan J, Stam AH, et al.

    Neurology 2018; (90(7)):e575-e582 doi:10.1212/WNL.0000000000004966.

    PMID: 29343472
  13. 13

    Defective glutamate and K+ clearance by cortical astrocytes in familial hemiplegic migraine type 2.

    Capuani C, Melone M, Tottene A, et al.

    EMBO molecular medicine 2016; (8(8)):967-86 doi:10.15252/emmm.201505944.

    PMID: 27354390
  14. 14

    Specific activation of GluN1-N2B NMDA receptors underlies facilitation of cortical spreading depression in a genetic mouse model of migraine with reduced astrocytic glutamate clearance.

    Crivellaro G, Tottene A, Vitale M, et al.

    Neurobiology of disease 2021; (156()):105419 doi:10.1016/j.nbd.2021.105419.

    PMID: 34111520
  15. 15

    Hyperexcitable interneurons trigger cortical spreading depression in an Scn1a migraine model.

    Auffenberg E, Hedrich UB, Barbieri R, et al.

    The Journal of clinical investigation 2021; (131(21)).

    PMID: 34546973
  16. 16

    Initiation of migraine-related cortical spreading depolarization by hyperactivity of GABAergic neurons and NaV1.1 channels.

    Chever O, Zerimech S, Scalmani P, et al.

    The Journal of clinical investigation 2021; (131(21)).

    PMID: 34491914
  17. 17

    Clinical characterization of a novel ATP1A2 p.Gly615Glu mutation in nine family members with familial hemiplegic migraine.

    Romozzi M, Spartano S, L'Erario FF, et al.

    Brain communications 2025; (7(1)):fcae447 doi:10.1093/braincomms/fcae447.

    PMID: 39723107
  18. 18

    Glutamate-system defects behind psychiatric manifestations in a familial hemiplegic migraine type 2 disease-mutation mouse model.

    Bøttger P, Glerup S, Gesslein B, et al.

    Scientific reports 2016; (6()):22047 doi:10.1038/srep22047.

    PMID: 26911348
  19. 19

    Progressive Ataxia with Hemiplegic Migraines: a Phenotype of CACNA1A Missense Mutations, Not CAG Repeat Expansions.

    Duque KR, Marsili L, Sturchio A, et al.

    Cerebellum (London, England) 2021; (20(1)):134-139 doi:10.1007/s12311-020-01185-9.

    PMID: 32888184

This page is for informational purposes only and does not constitute medical advice. Because hemiplegic migraine can resemble a stroke, seek urgent medical care for new, severe, or changing one-sided weakness rather than assuming it is migraine.